218 related articles for article (PubMed ID: 24211137)
1. Crystal structures of Sirt3 complexes with 4'-bromo-resveratrol reveal binding sites and inhibition mechanism.
Nguyen GT; Gertz M; Steegborn C
Chem Biol; 2013 Nov; 20(11):1375-85. PubMed ID: 24211137
[TBL] [Abstract][Full Text] [Related]
2. A molecular mechanism for direct sirtuin activation by resveratrol.
Gertz M; Nguyen GT; Fischer F; Suenkel B; Schlicker C; Fränzel B; Tomaschewski J; Aladini F; Becker C; Wolters D; Steegborn C
PLoS One; 2012; 7(11):e49761. PubMed ID: 23185430
[TBL] [Abstract][Full Text] [Related]
3. 4'-Bromo-resveratrol, a dual Sirtuin-1 and Sirtuin-3 inhibitor, inhibits melanoma cell growth through mitochondrial metabolic reprogramming.
George J; Nihal M; Singh CK; Ahmad N
Mol Carcinog; 2019 Oct; 58(10):1876-1885. PubMed ID: 31292999
[TBL] [Abstract][Full Text] [Related]
4. Structures of human sirtuin 3 complexes with ADP-ribose and with carba-NAD+ and SRT1720: binding details and inhibition mechanism.
Nguyen GT; Schaefer S; Gertz M; Weyand M; Steegborn C
Acta Crystallogr D Biol Crystallogr; 2013 Aug; 69(Pt 8):1423-32. PubMed ID: 23897466
[TBL] [Abstract][Full Text] [Related]
5. The plasticizer BBP selectively inhibits epigenetic regulator sirtuins.
Zhang J; Ali HI; Bedi YS; Choudhury M
Toxicology; 2015 Dec; 338():130-41. PubMed ID: 26520405
[TBL] [Abstract][Full Text] [Related]
6. Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.
Disch JS; Evindar G; Chiu CH; Blum CA; Dai H; Jin L; Schuman E; Lind KE; Belyanskaya SL; Deng J; Coppo F; Aquilani L; Graybill TL; Cuozzo JW; Lavu S; Mao C; Vlasuk GP; Perni RB
J Med Chem; 2013 May; 56(9):3666-79. PubMed ID: 23570514
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of human SIRT1 activation by resveratrol.
Borra MT; Smith BC; Denu JM
J Biol Chem; 2005 Apr; 280(17):17187-95. PubMed ID: 15749705
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol serves as a protein-substrate interaction stabilizer in human SIRT1 activation.
Hou X; Rooklin D; Fang H; Zhang Y
Sci Rep; 2016 Nov; 6():38186. PubMed ID: 27901083
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol.
Cao D; Wang M; Qiu X; Liu D; Jiang H; Yang N; Xu RM
Genes Dev; 2015 Jun; 29(12):1316-25. PubMed ID: 26109052
[TBL] [Abstract][Full Text] [Related]
10. Alkylresorcinols activate SIRT1 and delay ageing in Drosophila melanogaster.
Kayashima Y; Katayanagi Y; Tanaka K; Fukutomi R; Hiramoto S; Imai S
Sci Rep; 2017 Mar; 7():43679. PubMed ID: 28252007
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol is not a direct activator of SIRT1 enzyme activity.
Beher D; Wu J; Cumine S; Kim KW; Lu SC; Atangan L; Wang M
Chem Biol Drug Des; 2009 Dec; 74(6):619-24. PubMed ID: 19843076
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, and Biological Evaluation of 8-Mercapto-3,7-Dihydro-1
Han H; Li C; Li M; Yang L; Zhao S; Wang Z; Liu H; Liu D
Molecules; 2020 Jun; 25(12):. PubMed ID: 32549218
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of carba-NAD and the structures of its ternary complexes with SIRT3 and SIRT5.
Szczepankiewicz BG; Dai H; Koppetsch KJ; Qian D; Jiang F; Mao C; Perni RB
J Org Chem; 2012 Sep; 77(17):7319-29. PubMed ID: 22849721
[TBL] [Abstract][Full Text] [Related]
14. Discovery and mechanism study of SIRT1 activators that promote the deacetylation of fluorophore-labeled substrate.
Wu J; Zhang D; Chen L; Li J; Wang J; Ning C; Yu N; Zhao F; Chen D; Chen X; Chen K; Jiang H; Liu H; Liu D
J Med Chem; 2013 Feb; 56(3):761-80. PubMed ID: 23316803
[TBL] [Abstract][Full Text] [Related]
15. Molecular architecture of the human protein deacetylase Sirt1 and its regulation by AROS and resveratrol.
Lakshminarasimhan M; Curth U; Moniot S; Mosalaganti S; Raunser S; Steegborn C
Biosci Rep; 2013 May; 33(3):. PubMed ID: 23548308
[TBL] [Abstract][Full Text] [Related]
16. Modulatory effect of resveratrol on SIRT1, SIRT3, SIRT4, PGC1α and NAMPT gene expression profiles in wild-type adult zebrafish liver.
Schirmer H; Pereira TC; Rico EP; Rosemberg DB; Bonan CD; Bogo MR; Souto AA
Mol Biol Rep; 2012 Mar; 39(3):3281-9. PubMed ID: 21706162
[TBL] [Abstract][Full Text] [Related]
17. The controversial links among calorie restriction, SIRT1, and resveratrol.
Hu Y; Liu J; Wang J; Liu Q
Free Radic Biol Med; 2011 Jul; 51(2):250-6. PubMed ID: 21569839
[TBL] [Abstract][Full Text] [Related]
18. Sirt1 activation by resveratrol is substrate sequence-selective.
Lakshminarasimhan M; Rauh D; Schutkowski M; Steegborn C
Aging (Albany NY); 2013 Mar; 5(3):151-4. PubMed ID: 23524286
[TBL] [Abstract][Full Text] [Related]
19. Sirtuin activators.
Alcaín FJ; Villalba JM
Expert Opin Ther Pat; 2009 Apr; 19(4):403-14. PubMed ID: 19441923
[TBL] [Abstract][Full Text] [Related]
20. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1.
Pacholec M; Bleasdale JE; Chrunyk B; Cunningham D; Flynn D; Garofalo RS; Griffith D; Griffor M; Loulakis P; Pabst B; Qiu X; Stockman B; Thanabal V; Varghese A; Ward J; Withka J; Ahn K
J Biol Chem; 2010 Mar; 285(11):8340-51. PubMed ID: 20061378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
